Laurent Vernhet

2.6k total citations
72 papers, 2.0k citations indexed

About

Laurent Vernhet is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Laurent Vernhet has authored 72 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 19 papers in Pulmonary and Respiratory Medicine and 13 papers in Oncology. Recurrent topics in Laurent Vernhet's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (19 papers), Drug Transport and Resistance Mechanisms (12 papers) and Retinoids in leukemia and cellular processes (11 papers). Laurent Vernhet is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (19 papers), Drug Transport and Resistance Mechanisms (12 papers) and Retinoids in leukemia and cellular processes (11 papers). Laurent Vernhet collaborates with scholars based in France, Germany and Spain. Laurent Vernhet's co-authors include Olivier Fardel, Claudie Morzadec, Anthony Lemarié, Nathalie Allain, S. Jouneau, Emilie Bourdonnay, Valérie Lecureur, Dominique Lagadic‐Gossmann, Arnaud Courtois and Lydie Sparfel and has published in prestigious journals such as The Journal of Immunology, Cancer Research and Oncogene.

In The Last Decade

Laurent Vernhet

70 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Laurent Vernhet France	28	720	396	386	356	340	72	2.0k
Wanqing Liu United States	33	1.7k 2.4×	201 0.5×	157 0.4×	693 1.9×	576 1.7×	143	3.8k
Juan Tang China	29	1.2k 1.6×	193 0.5×	234 0.6×	196 0.6×	178 0.5×	110	2.5k
Zeynep Madak‐Erdogan United States	29	1.3k 1.8×	181 0.5×	264 0.7×	480 1.3×	139 0.4×	67	2.5k
Philip E. James United Kingdom	34	928 1.3×	192 0.5×	248 0.6×	75 0.2×	225 0.7×	102	3.4k
Diana Patricia Portales‐Pérez Mexico	28	516 0.7×	148 0.4×	852 2.2×	151 0.4×	62 0.2×	112	2.4k
Valérie Lecureur France	32	1.0k 1.4×	425 1.1×	683 1.8×	1.3k 3.6×	392 1.2×	72	3.6k
Zhong‐Ning Lin China	27	684 0.9×	478 1.2×	110 0.3×	129 0.4×	177 0.5×	62	1.9k
Thomas H. March United States	25	858 1.2×	320 0.8×	214 0.6×	201 0.6×	579 1.7×	59	2.1k
Subbarao V. Kala United States	20	612 0.8×	367 0.9×	50 0.1×	164 0.5×	105 0.3×	28	1.6k
Patricia E. Noker United States	18	625 0.9×	563 1.4×	96 0.2×	604 1.7×	204 0.6×	28	2.4k

Countries citing papers authored by Laurent Vernhet

Since Specialization

Citations

This map shows the geographic impact of Laurent Vernhet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laurent Vernhet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laurent Vernhet more than expected).

Fields of papers citing papers by Laurent Vernhet

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laurent Vernhet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laurent Vernhet. The network helps show where Laurent Vernhet may publish in the future.

Co-authorship network of co-authors of Laurent Vernhet

This figure shows the co-authorship network connecting the top 25 collaborators of Laurent Vernhet. A scholar is included among the top collaborators of Laurent Vernhet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laurent Vernhet. Laurent Vernhet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Joannes, Audrey, Claudie Morzadec, Stéphanie Guillot, et al.. (2023). Anti-fibrotic effects of nintedanib on lung fibroblasts derived from patients with Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs). Pulmonary Pharmacology & Therapeutics. 83. 102267–102267. 6 indexed citations

Lelong, M, Audrey Joannes, S. Jouneau, et al.. (2023). Effects of Ruxolitinib on fibrosis in preclinical models of systemic sclerosis. International Immunopharmacology. 116. 109723–109723. 16 indexed citations

Jouneau, S., Chloé Rousseau, Mathieu Léderlin, et al.. (2022). Malnutrition and decreased food intake at diagnosis are associated with hospitalization and mortality of idiopathic pulmonary fibrosis patients. Clinical Nutrition. 41(6). 1335–1342. 26 indexed citations

Jouneau, S., Bruno Crestani, Ronan Thibault, et al.. (2021). Post hoc Analysis of Clinical Outcomes in Placebo- and Pirfenidone-Treated Patients with IPF Stratified by BMI and Weight Loss. Respiration. 101(2). 142–154. 16 indexed citations

Jouneau, S., Chloé Rousseau, Alain Lescoat, et al.. (2021). Usefulness of Body Composition CT Analysis in Patients with Idiopathic Pulmonary Fibrosis: A Pilot Study. Academic Radiology. 29. S191–S201. 12 indexed citations

Jouneau, S., M. Kerjouan, Chloé Rousseau, et al.. (2018). What are the best indicators to assess malnutrition in idiopathic pulmonary fibrosis patients? A cross-sectional study in a referral center. Nutrition. 62. 115–121. 38 indexed citations

Pfister, Hugo, Laurent Madec, Pierre Le Cann, et al.. (2018). Factors determining the exposure of dairy farmers to thoracic organic dust. Environmental Research. 165. 286–293. 17 indexed citations

Morzadec, Claudie, et al.. (2014). Nrf2 expression and activity in human T lymphocytes: stimulation by T cell receptor activation and priming by inorganic arsenic and tert-butylhydroquinone. Free Radical Biology and Medicine. 71. 133–145. 58 indexed citations

Martin‐Chouly, Corinne, Claudie Morzadec, Mélodie Bonvalet, et al.. (2011). Inorganic arsenic alters expression of immune and stress response genes in activated primary human T lymphocytes. Molecular Immunology. 48(6-7). 956–965. 41 indexed citations

10.

Lemarié, Anthony, Emilie Bourdonnay, Claudie Morzadec, Olivier Fardel, & Laurent Vernhet. (2008). Inorganic Arsenic Activates Reduced NADPH Oxidase in Human Primary Macrophages through a Rho Kinase/p38 Kinase Pathway. The Journal of Immunology. 180(9). 6010–6017. 54 indexed citations

11.

Vernhet, Laurent, Claudie Morzadec, Julien van Grevenynghe, et al.. (2008). Inorganic arsenic induces necrosis of human CD34‐positive haematopoietic stem cells. Environmental Toxicology. 23(2). 263–268. 10 indexed citations

12.

Rébillard, Amélie, Xavier Tekpli, Olivier Meurette, et al.. (2007). Cisplatin-Induced Apoptosis Involves Membrane Fluidification via Inhibition of NHE1 in Human Colon Cancer Cells. Cancer Research. 67(16). 7865–7874. 131 indexed citations

13.

Lemarié, Anthony, Claudie Morzadec, Emilie Bourdonnay, Olivier Fardel, & Laurent Vernhet. (2006). Human Macrophages Constitute Targets for Immunotoxic Inorganic Arsenic. The Journal of Immunology. 177(5). 3019–3027. 110 indexed citations

14.

Lemarié, Anthony, Claudie Morzadec, Delphine Mérino, et al.. (2005). Arsenic Trioxide Induces Apoptosis of Human Monocytes during Macrophagic Differentiation through Nuclear Factor-κB-Related Survival Pathway Down-Regulation. Journal of Pharmacology and Experimental Therapeutics. 316(1). 304–314. 68 indexed citations

15.

Vernhet, Laurent, Nathalie Allain, Marc Le Vée, et al.. (2003). Blockage of Multidrug Resistance-Associated Proteins Potentiates the Inhibitory Effects of Arsenic Trioxide on CYP1A1 Induction by Polycyclic Aromatic Hydrocarbons. Journal of Pharmacology and Experimental Therapeutics. 304(1). 145–155. 32 indexed citations

16.

Vernhet, Laurent, et al.. (2001). Resistance of human multidrug resistance-associated protein 1-overexpressing lung tumor cells to the anticancer drug arsenic trioxide11Abbreviations: MRP1, multidrug resistance-associated protein 1; As2O3, arsenic trioxide; MTT, 3-(4-5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; and BSO, buthionine sulfoximine.. Biochemical Pharmacology. 61(11). 1387–1391. 43 indexed citations

17.

Courtois, Arnaud, Léa Payen, Laurent Vernhet, et al.. (1999). Inhibition of multidrug resistance-associated protein (MRP) activity by rifampicin in human multidrug-resistant lung tumor cells. Cancer Letters. 139(1). 97–104. 24 indexed citations

18.

Laupèze, Béatrice, Laurence Amiot, Arnaud Courtois, et al.. (1999). Use of the anionic dye carboxy-2',7'-dichlorofluorescein for sensitive flow cytometric detection of multidrug resistance-associated protein activity.. International Journal of Oncology. 15(3). 571–6. 31 indexed citations

19.

Robert, J.-M., Guillaume Le Baut, Christine Bobin‐Dubigeon, et al.. (1998). Synthesis and Potent Tumour Necrosis Factor-α Production Inhibitory Activity of N-Pyridinylphthalimides and Derivatives. Pharmacy and Pharmacology Communications. 4(1). 27–31. 1 indexed citations

20.

Hichami, Aziz, Véronique Leblais, Laurent Vernhet, et al.. (1997). Modulation of Platelet‐Activating‐Factor Production by Incorporation of Naturally Occurring 1‐O‐Alkylglycerols in Phospholipids of Human Leukemic Monocyte‐Like THP‐1 Cells. European Journal of Biochemistry. 250(2). 242–248. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact